Literature DB >> 9657686

High-efficiency incorporation in vivo of tyrosine analogues with altered hydroxyl acidity in place of the catalytic tyrosine-14 of Delta 5-3-ketosteroid isomerase of Comamonas (Pseudomonas) testosteroni: effects of the modifications on isomerase kinetics.

B Brooks1, R S Phillips, W F Benisek.   

Abstract

Versions of the Y55F/Y88F modified form of Delta 5-3-ketosteroid isomerase in which the active-site tyrosine-14 is replaced by 2-fluorotyrosine, 3-fluorotyrosine, and 2,3-difluorotyrosine, amino acids having progressively greater acidity of their phenolic hydroxyls, have been expressed in an Escherichia coli host and purified to high homogeneity. The steady-state kinetic properties of Y55F/Y88F KSI and its fluorotyrosine modified forms have been determined. The mechanistic implications of the results are presented and discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657686     DOI: 10.1021/bi980454x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Synthesis of 3,5-difluorotyrosine-containing peptides: application in substrate profiling of protein tyrosine phosphatases.

Authors:  Bhaskar Gopishetty; Lige Ren; Tiffany M Waller; Anne-Sophie Wavreille; Miguel Lopez; Amit Thakkar; Jinge Zhu; Dehua Pei
Journal:  Org Lett       Date:  2008-09-18       Impact factor: 6.005

2.  Using unnatural amino acids to probe the energetics of oxyanion hole hydrogen bonds in the ketosteroid isomerase active site.

Authors:  Aditya Natarajan; Jason P Schwans; Daniel Herschlag
Journal:  J Am Chem Soc       Date:  2014-05-14       Impact factor: 15.419

3.  Biophysical Characterization of Fluorotyrosine Probes Site-Specifically Incorporated into Enzymes: E. coli Ribonucleotide Reductase As an Example.

Authors:  Paul H Oyala; Kanchana R Ravichandran; Michael A Funk; Paul A Stucky; Troy A Stich; Catherine L Drennan; R David Britt; JoAnne Stubbe
Journal:  J Am Chem Soc       Date:  2016-06-21       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.